Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
在佛罗里达州大麻股合法化失败后，MariMed是否是一个安全的避风港？
Cannabis company MariMed Inc. (NASDAQ:MRMD) released its Q3 2024 results on November 6, announcing revised guidance for the fiscal year. While the company expects an 18–20% decline in EBITDA – down from its prior projection of flat to 2% growth – it raised its sales guidance to a 6–8% increase, up from 5–7%. These adjustments align closely with earlier projections from Zuanic & Associates, a cannabis industry research firm.
大麻公司MariMed Inc.（纳斯达克股票代码：MRMD）于11月6日发布了其2024年第三季度的业绩，宣布修订了财年指引。虽然公司预计EBITDA将下降18-20％，低于此前平稳增长至2％的预测，但其销售指引提高至6-8％的增长，高于5-7％。这些调整与Zuanic＆Associates之前的预测相近，该公司是一家大麻行业研究公司。
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. You can't afford to miss out if you're serious about the...
在Benzinga获取独家分析，并每天免费获得关于大麻业务和市场的头条新闻。立...
登录免费看全文
登录/注册
热门讨论
特斯拉绩后巨震，后市你怎么看？
特斯拉2024年Q4营收257.1亿美元，同比增长2%，不及预期。Cybercab计划2026年投产，预计车辆业务将于2025年恢复增长。面对特朗普回归，特斯拉股价能否在2025年继续攀升？
Moo Earnings
01/24 10:26
TSLA财报预告：通过猜测开盘价来获取奖励！